lecture 4 - Basic concepts in neuropharmacology Flashcards

1
Q

What is a drug?

A

A chemical substance of known structure, other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect.”

With some exceptions, drugs act on target proteins, namely:
– receptors
– enzymes
– carriers
– ion channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a receptor?

A

Protein molecules whose function is to recognise and respond to endogenous chemical signals.”

NB: ‘Receptor’ is sometimes used to denote any target molecule with which a drug molecule has to combine in order to elicit its specific effect.
For example, the voltage-sensitive sodium channel is sometimes referred to as the ‘receptor’ for local anaesthetics or the enzyme dihydrofolate reductase as the ‘receptor’ for methotrexate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two-state model of receptor activation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two-state model of receptor activation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drug

A

Chemical applied to a physiological system that affects its function in a specific way.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ligand

A

Any molecule or atom which binds reversibly to a protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Agonist

A

Drugs which ‘activate’ receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antagonist

A

A drug that binds to the receptor without causing activation, and therefore block the effect of agonists on that receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The Relation Between Drug Concentration and Effect

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Different classes of drugs differentially impact the fraction of receptors in the activated (R*) state

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antagonists reduce agonist binding

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Two-state model of receptor activation

A

prevent agonist
prevent inverse font going back to reverse state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Affinity

A

How well a drug binds its receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Efficacy

A

How well a drug once bound to a receptor elicits a response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potency

A

A measure of the amount of drug required to elicit a response of a given intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

two state model - affinity/ efficacy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Potency Vs. Efficacy

A

Which agonist(s) are the least potent? B

Which drug(s) have the greatest efficacy? A/B

Which drug(s) are partial agonists? C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Orthosteric
site

A

The primary ligand binding site of a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Allosteric
site

A

A site distinct from the endogenous ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Allosteric modulators impact receptor function by …

A

binding at a site distinct from the endogenous ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does allosteric modulation impact dose response curves?

22
Q

Neurotransmitter =

A

Biochemical that mediates fast-acting direct communication between two neurons (pre- and post-synaptic)

23
Q

Neuromodulator =

A

= Biochemical that modulates activity of neurons and neural networks by changing the ability of neurons to response to neurotransmitters. Can act locally or at sites remote from where they are synthesized.

Some neurotransmitters can also act as neuromodulators

24
Q

‘Traditional’ Small molecule Neurotransmitters

25
Q

‘traditional’ small molecule transmitters

A

Examples
Glutamate, 5-HT
GABA, dopamine
Acetylcholine

Targets
Ligand-gated ion channels, GPCRs

Main functional role
Fast & Slow synaptic transmission,
neuromodulation

26
Q

Neuropeptides

A

Examples
Substance P, Neuropeptide Y, Endorphins

Targets
GPCRs

Main functional role
neuromodulation

27
Q

Lipid mediators

A

Examples
Prostoglandins
Endocannabinoids

Targets
GPCRs

Main functional role
neuromodulation

28
Q

Nitric Oxide

A

Targets
Guanylyl cyclase

Main functional role
neuromodulation

29
Q

Neurotrophins, cytokines

A

Examples
Brain derived neurotrophic factor, interleukin-1

Targets
Kinase-linked receptors

Main functional role
Neuronal growth, survival, functional plasticity

30
Q

Steroids

A

Examples
Androgens, oestrogens

Targets
Nuclear and membrane receptors

Main functional role
Functional plasticity

31
Q

Nitric oxide Signalling modulates neurotransmission

A
  • Ca2+ influx into cells downstream of ion-channel opening leads to activation of neuronal nitric oxide synthase (nNOS) which increases intracellular nitric oxide (NO) levels.
  • NO activates cGMP and MAPK signalling which modulates function of the postsynaptic neuron.
  • NO can also diffuse retrogradely and impact neurotransmitter release from the presynaptic neurons.
32
Q

Glial cells

A

release transmitters which can modulate neuronal activity

33
Q

Gliotransmitters

A

Glutamate
ATP
Adenosine
D-serine
Eicosanoids (e.g. prostaglandins)
Cytokines (e.g. TNFα)
Neuropeptides

34
Q

Ionotropic =

A

Ligand gated ion channels

35
Q

Metabotropic =

A

Receptors that couple through secondary messenger e.g. GPCRs, tyrosine kinase linked receptors. May indirectly regulate ion channel opening.

36
Q

Ionotropic Receptors (ligand-gated ion channels)

A
  • Activated by binding of neurotransmitters
  • Channel open
    Ions flow into the postsynaptic cell:
    Na+ –> Depolarisation
    Ca2+ –> Some depolarisation, biochemical cascades, changes in gene expression
37
Q

Ionotropic Receptors (ligand-gated ion channels) types

38
Q

Generic features of ligand-gated ion channels

A
  • Typically heteromeric assemblies of 4 or 5 subunits
  • Each subunit has transmembrane spanning helices which when assembled form a central aqueous channel
  • Ligand binding –> channel opening = milliseconds
39
Q

Metabotropic Receptors

A
  • Not directly coupled to ion channels
  • Can regulate ion channel opening :
    –> downstream of neurotransmitter binding
    –> takes more time
40
Q

G-protein coupled receptors

A
  • Ligand binding induces GDP to GTP exchange on the Gα subunit
  • Gα subunit dissociates from βy complex
  • Gα subunit and βy complex activate downstream targets
  • When bound to target GTPase activity of Gα subunit is increased leading to hydrolysis of GTP to GDP
41
Q

Stimulation of GPCRs can activate many different downstream effectors

A
  • Adenylyl cyclase (AC) – cAMP formation
  • Phospholipases
  • PLC = inositol phosphate and diacylglycerol formation
  • PLA2 = arachidonic acid (AA) and ecosanoid formation
  • Kinases e.g. MAPK, PI3K
  • Ion channels
  • Gene transcription (via MAPK, PKA/CREB)
42
Q

The main g-protein subtypes

A

Gαs
Gαi/o
Gαq
Gβg

43
Q

Gαs

A

Main effectors
Stimulates adenylyl cyclase, causing increased cAMP formation

Example receptor
Catecholamine, Histamine, 5-HT, opioids, cannabinoid

44
Q

Gαi/o

A

Main effectors
Inhibits adenylyl cyclase, causing decreased cAMP formation

Example receptor
receptors

45
Q

Gαq

A

Main effectors
Activated phospholipase C, increasing production of second messengers e.g. inositol triphosphate and diacylglycerol

Example receptor
Amine, prostanoid and peptide receptors

46
Q

Gβy

A

Main effectors
As for Gα subunits above plus:
Ion channels, GPCR kinases, MAPK

Example receptor
All GPCRs

47
Q

Example GPCR in the CNS: Metabotropic glutamate receptors

48
Q

Kinase linked receptors

A

1 and 2. Ligand-binding leads to dimerization of receptors
3. Receptor dimers undergo auto-phosphorylation at tyrosine (Tyr) residues
4. pTyr sites recruit proteins with SH2 domains leading to activation of downstream signalling e.g. STAT transcription factors, members of the RAS/Raf/MAPK pathway

49
Q

Cytokine receptors

A
  • are tyrosine kinase linked receptors
  • Cytokines are neuromodulators in the CNS
  • Can activate multiple down stream signalling cascades including transcription factors that modulate gene expression
  • Cytokine receptors are regulated by endogenous negative feedback mechanisms
50
Q

Nuclear (hormone) receptors

A

Examples – Glucocorticoid receptor, oestrogen receptor, androgen receptor
Typically neuromodulatory e.g. steroid hormones can modulate expression of receptors for ‘traditional’ small molecule neurotransmitters

51
Q

Summary: CNS Receptor types